Rare Diseases Trial Network Moves Closer to Reality

As many as 30 million Americans may be living with a “rare disease,” officially defined as a condition affecting fewer than 200,000 people.

The Genetic and Rare Diseases Information Center says there are some 7,000 known rare diseases. Most are genetic. Only about 10% of all rare diseases have an approved treatment.

To hasten the development of drugs and therapies, the Food and Drug Administration in 2019 began an initiative to “to facilitate a cooperative approach and common standardized platforms to better characterize rare diseases, incorporate the patient’s perspective in clinical outcome assessment measures, and build clinical trial readiness in the pre-competitive space.”

Dubbed the Rare Disease Cures Accelerator, the initial focus of the program is building “an integrated database and analytics hub designed to promote the secure sharing of existing patient-level data and encourage the standardization of new data collection.”

A second key part was to award grants “develop standard core sets of clinical outcome assessments (COAs) and endpoints for specific disease indications.”

In May, the FDA asked for input from industry, rare disease organizations, patients and others regarding the “implementation and sustainment of global clinical trials networks.”

“As drug development for rare diseases can be challenging due to the small number of patients and limited understanding of the variability and progression of the diseases, the FDA is committed to developing bold new approaches to harness the infrastructure of global clinical trial networks,” said Anand Shah, FDA deputy commissioner for medical and scientific affairs.

A recent report on Regulatory Focus, the website of the Regulatory Affairs Professionals Society, said the stakeholders who commented “called for regulatory clarity, smart use of existing resources, and a move toward harmonized trial standards and assessments.”

Several comments addressed the need to ensure the quality of the data collected as well as reducing and eliminating some of the challenges unique to rare disease trials.

On behalf of the Biotechnology Innovation Organization, Danielle Friend, senior director of science and regulatory affairs, said the networks need to support “the collection of high-quality data that are endorsed by the agency for regulatory decision-making.” She said a rare disease network must recognize and address “heterogeneity in rare diseases, lack of harmonization among global regulators in rare disease regulatory policy, and current inconsistencies in clinical trial network operation.” The FDA plan also should consider combining rare diseases into a single trial when possible.

The National Organization for Rare Diseases echoed those comments, and, according to Regulatory Focus, said “Increased collaboration and a focus on increasing the speed and success of clinical trials can have the effect of ‘breaking down the silos of activity currently taking place in rare disease research.’”

Now the FDA will analyze the comments, incorporating them into a development plan for its trials networks program. No timeline was given for this phase of the program.

Photo by CDC on Unsplash

#WeAreGreenKey: Spotlight on Lauren Scutero
General Interest Green Key News Pharma Worklife

#WeAreGreenKey: Spotlight on Lauren Scutero

#WeAreGreenKey: Spotlight on Anthony Agosto
Accounting + Finance General Interest Green Key News Human Resources Leadership + Management Worklife

#WeAreGreenKey: Spotlight on Anthony Agosto

Shop for Jobs this Holiday Weekend
General Interest Green Key News Human Resources Worklife

Shop for Jobs this Holiday Weekend

Thankful for Our Community this Thanksgiving
General Interest Green Key News Leadership + Management Worklife

Thankful for Our Community this Thanksgiving

Green Key Unlocked: Behavioral Interviews in IT
General Interest Green Key News Information Technology Worklife

Green Key Unlocked: Behavioral Interviews in IT

#WeAreGreenKey: Spotlight on Stu Leifer
Accounting + Finance General Interest Green Key News Worklife

#WeAreGreenKey: Spotlight on Stu Leifer

#WeAreGreenKey: Spotlight on Sam Jaberi
General Interest Green Key News Information Technology Worklife

#WeAreGreenKey: Spotlight on Sam Jaberi

Preparing for Different Types of Interviews
General Interest Green Key News Human Resources Worklife

Preparing for Different Types of Interviews

Benefits of Working Hybrid
General Interest Green Key News Worklife

Benefits of Working Hybrid

Green Key Unlocked: How to Succeed in Desktop Support
General Interest Green Key News Information Technology Worklife

Green Key Unlocked: How to Succeed in Desktop Support

#WeAreGreenKey: Spotlight on Andrew List
Financial Services General Interest Green Key News Worklife

#WeAreGreenKey: Spotlight on Andrew List

How to Improve Sleep Hygiene (For a Better Work-Life Balance)
General Interest Green Key News Healthcare Worklife

How to Improve Sleep Hygiene (For a Better Work-Life Balance)

#WeAreGreenKey: Spotlight on Karlina Cordero
General Interest Green Key News Human Resources Worklife

#WeAreGreenKey: Spotlight on Karlina Cordero

How to Ask for a Raise
General Interest Green Key News Worklife

How to Ask for a Raise

#WeAreGreenKey: Spotlight on Brittany Kinsella
General Interest Green Key News Leadership + Management Worklife

#WeAreGreenKey: Spotlight on Brittany Kinsella

Green Key Unlocked: Why Green Key?
Accounting + Finance Architecture + Engineering Financial Services General Interest Green Key News Healthcare Human Resources Information Technology Leadership + Management Legal Support Marketing Technology Pharma Professional Support Worklife

Green Key Unlocked: Why Green Key?

#WeAreGreenKey: Spotlight on Samantha Leveille
Architecture + Engineering General Interest Green Key News Worklife

#WeAreGreenKey: Spotlight on Samantha Leveille

How to Answer Salary Expectations
General Interest Green Key News Worklife

How to Answer Salary Expectations

#WeAreGreenKey: Spotlight on Sean Coyne
Architecture + Engineering General Interest Green Key News Worklife

#WeAreGreenKey: Spotlight on Sean Coyne

Questions to Ask During a Job Interview
General Interest Green Key News Human Resources Worklife

Questions to Ask During a Job Interview

Latest Blog Posts
View All Posts
#WeAreGreenKey: Spotlight on Lauren Scutero

#WeAreGreenKey: Spotlight on Lauren Scutero

Lauren has about 18 years of pharmaceutical recruiting experience, with no end in sight.
Read More
#WeAreGreenKey: Spotlight on Anthony Agosto

#WeAreGreenKey: Spotlight on Anthony Agosto

Anthony has been with Green Key for over eight years and has played an integral role in the success of...
Read More
Shop for Jobs this Holiday Weekend

Shop for Jobs this Holiday Weekend

This coming weekend may call for hearty food, crazy sales, and some quality down time to unwind. But while you're...
Read More